These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6986976)
1. Comparison of tamoxifen and hypophysectomy in breast cancer treatment. Kiang DT; Frenning DH; Vosika GJ; Kennedy BJ Cancer; 1980 Mar; 45(6):1322-5. PubMed ID: 6986976 [TBL] [Abstract][Full Text] [Related]
2. Antiestrogen-induced remissions in stage IV breast cancer. Manni A; Trujillo J; Marshall JS; Pearson OH Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225 [TBL] [Abstract][Full Text] [Related]
3. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer. Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405 [TBL] [Abstract][Full Text] [Related]
4. Antihormone treatment of stage IV breast cancer. Manni A; Trujillo JE; Marshall JS; Brodkey J; Pearson OH Cancer; 1979 Feb; 43(2):444-50. PubMed ID: 421171 [TBL] [Abstract][Full Text] [Related]
5. Role of pituitary hormones in the growth of human breast cancer. Pearson OH; Manni A; Chambers M; Brodkey J; Marshall JS Cancer Res; 1978 Nov; 38(11 Pt 2):4323-6. PubMed ID: 212192 [TBL] [Abstract][Full Text] [Related]
6. [Hormonal treatment of breast tumor]. Garcia Giralt E; Omodei Zorini C Clin Ter; 1990 Feb; 132(4):217-27. PubMed ID: 2140308 [No Abstract] [Full Text] [Related]
7. Antiestrogen treatment of breast cancer: an overview. Pearson OH; Manni A; Arafah BM Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524 [TBL] [Abstract][Full Text] [Related]
8. Response of advanced breast cancer to total endocrine ablation after exacerbation on tamoxifen: results in seven patients and possible mechanism of action. Hartley JW; Wong J; Fletcher WS J Surg Oncol; 1987 Mar; 34(3):182-7. PubMed ID: 3821126 [TBL] [Abstract][Full Text] [Related]
9. Transsphenoidal hypophysectomy in breast cancer: evidence for an individual role of pituitary and gonadal hormones in supporting tumor growth. Manni A; Pearson OH; Brodkey J; Marshall JS Cancer; 1979 Dec; 44(6):2330-7. PubMed ID: 509401 [TBL] [Abstract][Full Text] [Related]
10. Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial. Thürlimann B; Hess D; Köberle D; Senn I; Ballabeni P; Pagani O; Perey L; Aebi S; Rochlitz C; Goldhirsch A Breast Cancer Res Treat; 2004 Jun; 85(3):247-54. PubMed ID: 15111763 [TBL] [Abstract][Full Text] [Related]
11. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer]. Novoa Vargas A; Font López KC; Amador DD Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856 [TBL] [Abstract][Full Text] [Related]
12. Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer. Manni A; Arafah BM; Pearson OH Cancer; 1981 Dec; 48(11):2507-9. PubMed ID: 7296499 [TBL] [Abstract][Full Text] [Related]
13. Hormonal therapy with tamoxifen in male breast cancer. Hortobagyi GN; DiStefano A; Legha SS; Buzdar AU; Blumenschein GR Cancer Treat Rep; 1979 Apr; 63(4):539-41. PubMed ID: 221118 [No Abstract] [Full Text] [Related]
14. A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. Buchanan RB; Blamey RW; Durrant KR; Howell A; Paterson AG; Preece PE; Smith DC; Williams CJ; Wilson RG J Clin Oncol; 1986 Sep; 4(9):1326-30. PubMed ID: 3528402 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.it. Boccardo F; Rubagotti A; Amoroso D; Mesiti M; Romeo D; Sismondi P; Giai M; Genta F; Pacini P; Distante V; Bolognesi A; Aldrighetti D; Farris A J Clin Oncol; 2000 Jul; 18(14):2718-27. PubMed ID: 10894871 [TBL] [Abstract][Full Text] [Related]
16. Management of breast cancer. Cohen IA; Keller JH; Abate MA Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963 [TBL] [Abstract][Full Text] [Related]
17. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy? Manni A; Trujillo J; Brodkey J; Marshall JS; Pearson OH Trans Assoc Am Physicians; 1977; 90():342-52. PubMed ID: 611666 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters. Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185 [TBL] [Abstract][Full Text] [Related]
19. [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study]. Gori S; Anastasi P; Marrocolo F Suppl Tumori; 2004; 3(4):S27-31. PubMed ID: 15206206 [No Abstract] [Full Text] [Related]
20. Additive hormonal therapy in women with advanced breast cancer. Ingle JN Cancer; 1984 Feb; 53(3 Suppl):766-77. PubMed ID: 6229323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]